Clinical Trial Page
Clinical Trial Results:
Treatment of the haematological relapse in patients suffering from acute myeloid leukaemia or myelodysplastic syndrome with 5-Azacytidin (Vidaza®) after hematopoietic stem cell transplantation "RELAZA"
| Summary | |
EudraCT number | 2006-001040-31 |
Trial protocol | DE |
Global completion date | 28 Sep 2011 |
| Paediatric regulatory details | |
Is the trial part of an agreed EMA paediatric investigation plan? | No |
Is the trial in scope of article 45 of Regulation (EC) No 1901/2006? | No |
Is the trial in scope of article 46 of Regulation (EC) No 1901/2006? | No |
| Results information | |
Results version number | v1(current) |
This version publication date | 10 Dec 2020 |
First version publication date | 10 Dec 2020 |
Other versions | |
Summary report(s) | 2006-001040-31_report |
Note: The legislation allows summary attachments to be posted instead of the full dataset for this trial. Refer to Commission Guideline 2012/C 302/03 for further information.